Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Medicine|September 15, 2018
A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapyYoungkeun Ahn, Yongcheol Kim, Kiyuk Chang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 19, 2022
Body Mass Index and Major Adverse Events During Chronic Antiplatelet Monotherapy After Percutaneous Coronary Intervention With Drug-Eluting Stents - Results From the HOST-EXAM TrialKi-Bum Won, Eun-Seok Shin, Jeehoon Kang, et al.
Plos One|May 12, 2015
Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencingSoo Min Han, Byungjin Hwang, Tae-gun Park, et al.
Clinical Therapeutics|August 25, 2021
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III StudySeung-Ah Lee, Weon Kim, Taek Jong Hong, et al.
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Discrepancies between home blood pressure and ambulatory blood pressure monitoring in apparent treatment-resistant hypertension: analysis from the Korean resistant hypertension cohortJiwon Seo, Chan Joo Lee, Dae-Hee Kim, et al.
Drug Design, Development and Therapy|June 18, 2015
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapyMoo-Yong Rhee, Sang Hong Baek, Weon Kim, et al.
Cardiovascular Therapeutics|August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Clinical Therapeutics|November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering EfficacyMoo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.
JAMA Cardiology|November 27, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural ComplexityJeehoon Kang, Jaewook Chung, Kyung Woo Park, et al.
Pageof 10